SynBioBeta Speaker

Krishna Kannan

Vice President, Product Development

Telesis Bio

YEAR

25

May 2025, SynBioBeta

Keynote Speaker

Krishna Kannan, Ph. D., MBA, is a biotechnology leader specializing in product development and synthetic biology. As Vice President of Product Development at Telesis Bio, he leads the commercialization of cutting-edge enzymatic DNA synthesis technologies, including the Gibson SOLA platform. With deep expertise in genome editing, DNA synthesis, and synthetic biology, Krishna has spearheaded the development of automated solutions for synthetic biology applications, enabling scalable and efficient workflows. His work includes pioneering genome synthesis efforts, launching innovative reagent kits, and driving strategic collaborations with industry leaders to advance molecular biology and automation technologies.

SynBioBeta 2025 - Keynote

Accelerating Biomanufacturing Through On-Demand Synthesis

This innovative approach leverages nucleic acid development from Telesis Bio and protein production from the Illinois Biological Foundry for Advanced Biomanufacturing. These thought leaders will discuss the streamlined and enhanced efficiency of producing complex biological molecules when integrating their advanced technologies, transforming the landscape of synthetic biology.

All Categories

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

Other Speakers

Other Speakers

Sign Up
Sign Up